TSXV:BTI.H - Post by User
Post by
fishtailon Dec 10, 2020 4:16pm
344 Views
Post# 32079276
Bioasis Announces Annual General Meeting Results
Bioasis Announces Annual General Meeting Results Bioasis Announces Annual General Meeting Results
December 10, 2020
GUILFORD, CONN., BIOASIS TECHNOLOGIES INC–Bioasis Technologies Inc. (TSX.V:BTI; OTCQB:BIOAF) (the “Company” or “Bioasis”), a pre-clinical, research-stage biopharmaceutical company developing its proprietary xB
3™ platform technology for the delivery of therapeutics across the blood-brain barrier (“BBB”) and the treatment of central nervous system (“CNS”) disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases, is pleased to announce that all resolutions were passed by requisite majority at its annual general meeting (“AGM”) held earlier today in New Haven, Conn., United States.
The four incumbent directors, Dr. Deborah A. Rathjen, John E. Curran, David M. Wurzer and Dr. Mario Saltarelli were re-elected by shareholders. Mr. John Hemeon was also elected to the Board by shareholders, bringing the total number of directors to five. Shareholders also approved the re-appointment of Manning Elliott LLP as auditors of the Company for the ensuing year.